FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma
about
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsEstrogens and stem cells in thyroid cancer.Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAFMetastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.The roles of FOXM1 in pancreatic stem cells and carcinogenesisFOXM1 and its oncogenic signaling in pancreatic cancer pathogenesisA novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).Casticin induces ovarian cancer cell apoptosis by repressing FoxM1 through the activation of FOXO3a.A novel microRNA, hsa-miR-6852 differentially regulated by Interleukin-27 induces necrosis in cervical cancer cells by downregulating the FoxM1 expression.Special types of thyroid carcinoma.UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1.3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
P2860
Q27027491-D44A1A22-6B65-4CA9-A71B-BCA6E358184BQ33358936-F5D4A896-3E0A-4160-BBA1-6E43E6CF1E26Q35554680-22D919DE-5A59-468E-8895-218F950ADF48Q35914464-288779D1-4D41-47FE-8EA0-FD4E6CF69A66Q36618887-F48A001A-02BD-41BC-995A-87E422955364Q36905783-4553E5D6-2594-4870-8A2E-045EDBF9A366Q37583296-3357B42C-6ECB-423E-B7F6-00D832C55460Q37716906-D34CF34E-B89D-401A-AE8F-89526D0D59A5Q37725502-BDF8D6F2-F7CA-4580-A2E6-A1D1262627AFQ38851509-0B638570-ABC9-4C79-A048-DB6A6803D710Q41998858-7DACC60A-83A3-4F51-BA22-79970678C226Q47552205-30EA5E6A-EB0A-4E32-91EC-D19716ABC3D7Q48120106-BD5C6CDA-4A1C-4B58-A194-93BBC92DA6E8Q52338003-FD37DAD8-3ABE-487F-AE9E-E8F275470DAEQ55517828-CD8F6F43-0B12-4D2D-BCB4-F32CF26FFB94
P2860
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
FOXM1 is a molecular determina ...... f anaplastic thyroid carcinoma
@ast
FOXM1 is a molecular determina ...... f anaplastic thyroid carcinoma
@en
type
label
FOXM1 is a molecular determina ...... f anaplastic thyroid carcinoma
@ast
FOXM1 is a molecular determina ...... f anaplastic thyroid carcinoma
@en
prefLabel
FOXM1 is a molecular determina ...... f anaplastic thyroid carcinoma
@ast
FOXM1 is a molecular determina ...... f anaplastic thyroid carcinoma
@en
P2093
P2860
P50
P356
P1476
FOXM1 is a molecular determina ...... f anaplastic thyroid carcinoma
@en
P2093
Carmelo Nucera
Clara Ugolini
Giuliana Salvatore
Maria Carmela Cantisani
Massimo Santoro
Paolo Salerno
Roberto Bellelli
Tito Claudio Nappi
Tomas Alvarez Gago
P2860
P304
P356
10.1530/ERC-12-0031
P577
2012-09-21T00:00:00Z